Product Images Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate

Each extended-release capsule contains a combination of Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate with a total dose of 3.1mg. For complete pre-treatment information, see the package insert. The medication should be stored at 20 to 25°C (68 to 77°F) and should be dispensed in a light-resistant container. The medication guide should be provided separately to each patient. This medication is distributed by Lannett Company Inc. and comes in a package of 100 capsules.*

This is a medication description. The extended-release capsule contains a combination of salts. The medication is used to treat attention deficit/hyperactivity disorder and narcolepsy. The proper storage includes keeping the capsules at 15 to 30°C and dispensing them in a light-resistant container. The medication guide should be provided separately for each patient. This medication is distributed by Lonnett Company, Inc. and is available in a package of 100 capsules.*

This is a medication guide for Dextroamphetamine Saccharate and Amphetamine Aspartate Monohydrate Extended-Release Capsules, which contains four active ingredients in one. The package includes 100 capsules with prescribing and usage directions. It must be stored at a temperature of 20°C to 25°C and dispensed in USP-defined light-resistant containers. For more information, visit the website of the manufacturer, Lannett Company, Inc.*

This is a description of a medication named Dextroamphetamine, which comes in the form of extended-release capsules. Each capsule contains a mix of various types of Amphetamines equivalent to 123 mg of amphetamine base. It is advised to consult the package insert for complete prescribing information. The medication should be stored in a controlled room temperature range of 20-25°C and should only be dispensed under the defined USP regulations. The manufacturer of the medication is Lannett Company, Inc. The medication guide can be accessed at www.lonnett.com/med-quide /dextro-amp-mps. The description also includes an NDC (National Drug Code) 0527-079337 and a batch code 79874 with a revised date of 0221.*

This is a description of a pharmaceutical product in a capsule form. The product is an extended-release capsule containing a mixture of Dextroomphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate with varying doses per ingredient. The capsule is packaged with a medication guide and must be dispensed by a licensed pharmacy. It is produced by Lonett Company, Inc. and should be stored in a controlled room temperature.*

This is a medication description for extended-release capsules containing a combination of Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate. Each capsule consists of 7.5 mg of the former two substances and 7.5 mg of the latter two substances, with a total equivalent of 18.8 mg of amphetamine base. This medication is to be dispensed with a medication guide to each patient. It is to be stored in a controlled environment between 20° to 25°C (68° to 77°F) and dispensed in a light-resistant container. More detailed information can be found in the enclosed package insert. Distributed by Lannett Company, Inc. with National Drug Code (NDC) 0527-0795-37.*